Article
Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.
Cancer immunology, immunotherapy : CII - 1 Jan 1991
Itoh K, Hayakawa K, Salmeron M A, Legha S S, Murray J L, Talpaz M, Balch C M, Parkinson D R, Lee K, Zukiwski A A
Abstract excerpt
Alteration in interactions between tumor-infiltrating lymphocytes (TILs) and tumor cells after chemotherapy or immunotherapy was studied in metastatic melanoma patients. Tumors were harvested from surgical specimens 17 days after the end of chemotherapy with cisplatin, vinblastine, and dacarbazine (CVD). Tumors of nonlymph-node metastases from two responders yielded neither TILs nor tumor cells, whereas those...
Topics
- Antineoplastic Combined Chemotherapy Protocols
- Cell Communication
- Cytotoxicity, Immunologic
- Humans
- Immunotherapy
- Interferon Type I
- Interleukin-2
- Lymphocytes, Tumor-Infiltrating
- Melanoma
- Neoplasm Metastasis
